Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival

Стратификация риска при хронической тромбоэмболической легочной гипертензии прогнозирует выживаемость
Barbro Kjellström, Gerhard Wikström, Göran Rådegran, Anna Sandqvist, David Kylhammar, Sven-Erik Bartfay, Roger Hesselstrand, Clara Hjalmarsson, Mohammad Kavianipour, Magnus Nisell, Stefan Söderberg
2020-06-26

ESC/ERS risk assessmentchronic thromboembolic pulmonary hypertensionpulmonary endarterectomyrisk stratificationsurvival prediction
Objectives To investigate if the pulmonary arterial hypertension (PAH) risk assessment tool presented in the 2015 ESC/ERS guidelines is valid for patients with chronic thromboembolic pulmonary hypertension (CTEPH) when taking pulmonary endarterectomy (PEA) into account. Design. Incident CTEPH patients registered in the Swedish PAH Registry (SPAHR) between 2008 and 2016 were included. Risk stratification performed at baseline and follow-up classified the patients as low-, intermediate-, or high-risk using the proposed ESC/ERS risk algorithm. Results. There were 250 CTEPH patients with median age (interquartile range) 70 (14) years, and 53% were male. Thirty-two percent underwent PEA within 5 (6) months. In a multivariable model adjusting for age, sex, and pharmacological treatment, patients with intermediate-risk or high-risk profiles at baseline displayed an increased mortality risk (Hazard Ratio [95% confidence interval]: 1.64 [0.69–3.90] and 5.39 [2.13–13.59], respectively) compared to those with a low-risk profile, whereas PEA was associated with better survival (0.38 [0.18–0.82]). Similar impact of risk profile and PEA was seen at follow-up. Conclusion. The ESC/ERS risk assessment tool identifies CTEPH patients with reduced survival. Furthermore, PEA improves survival markedly independently of risk group and age. Take home message: The ESC/ERS risk stratification for PAH predicts survival also in CTEPH patients, even when taking PEA into account.
1
At baseline, high-risk patients had substantially greater mortality than low-risk patients (HR 5.39, 95% CI 2.13–13.59), while intermediate-risk patients showed a nonsignificant increase (HR 1.64, 95% CI 0.69–3.90).
2
Pulmonary endarterectomy improved survival independently of baseline risk group and age.
3
Pulmonary endarterectomy was associated with markedly better survival (HR 0.38, 95% CI 0.18–0.82) after adjustment for age, sex, and pharmacological treatment.
4
Risk profile and pulmonary endarterectomy showed similar associations with survival at follow-up, indicating prognostic value over time.
5
The 2015 ESC/ERS PAH risk assessment tool effectively predicts survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH).

Patients with chronic thromboembolic pulmonary hypertension (CTEPH), including those undergoing pulmonary endarterectomy (PEA)

The association of ESC/ERS risk profiles and pulmonary endarterectomy with survival

Publication Details
Publication Date
2020-06-26
Journal
Publisher
ISSN
Cited by
28
Access Type
Author Information
Authors
Barbro Kjellström
Gerhard Wikström
Göran Rådegran
Anna Sandqvist
David Kylhammar
Sven-Erik Bartfay
Roger Hesselstrand
Clara Hjalmarsson
Mohammad Kavianipour
Magnus Nisell
Stefan Söderberg
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%